MeiraGTx Holdings plc (MGTX) Pre-Tax Margin
- 2020-12-31: Pre-Tax Margin -276.17%.
- 2020-09-30: Pre-Tax Margin -126.31%.
- 2020-06-30: Pre-Tax Margin -1027.40%.
- 2019-12-31: Pre-Tax Margin -72.75%.
Complete source-backed pre-tax margin history.
- Available history
- 2019-06-30 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2020-12-31 | -276.17% |
| 2020-09-30 | -126.31% |
| 2020-06-30 | -1027.40% |
| 2019-12-31 | -72.75% |
| 2019-09-30 | -301.44% |
| 2019-06-30 | -1055.36% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -140.31% |
| 2024-12-31 | -444.10% |
| 2023-12-31 | -599.46% |
| 2022-12-31 | -814.16% |
| 2021-12-31 | -211.03% |
| 2020-12-31 | -372.63% |
| 2019-12-31 | -411.87% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |